对于MRSA感染而言,以纳米载体为媒介提供万科米的潜力
Vincent O Nyandoro1,2, Eman A Ismail1,3, Abdelrahman Tageldin1
1Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Expert opinion on drug delivery
|February 14, 2025
概括
纳米载体增强了万科米辛的输送,以对抗抗甲素耐药的金黄色葡萄球菌 (MRSA) 感染. 这种方法提高了疗效,减少了毒性,并有助于克服抗生素耐药性.
科学领域:
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 构成全球健康威胁,原因是它对万科米的耐药性.
- 作为标准治疗方法的万科米辛具有诸如毒性和细胞内透性差等局限性.
- 通过纳米载体介导的输送提供了一种创新的策略,以克服这些范胺的局限性.
研究的目的:
- 探索纳米载体对抗MRSA的万科素传递的潜力.
- 审查纳米载体如何降低系统毒性并增强抗MRSA活性.
- 检查建模和模拟在理解范素-纳米载体相互作用中的作用.
主要方法:
- 2017年至2024年间发表的实验性文章的文献综述.
- 在主要的科学数据库中进行的搜索:科学网,谷歌学者,PubMed和Scopus.
- 对研究的分析,重点是用于范科米输送和MRSA治疗的纳米载体系统.
主要成果:
- 纳米载体可以作为万科米辛的有效传递系统,可能提供协同抗菌效应.
- 通过纳米载体的持续释放和有针对性的输送,可以在感染部位达到更高的治疗度.
- 通过纳米载体减少万科米辛剂量,最大限度地降低系统性毒性,改善患者的治疗结果.
- 模拟技术提供了对万素-纳米载体相互作用的见解,有助于纳米系统优化.
结论:
- 通过纳米载体介导的万科米辛输送显示出对抗MRSA感染的显著前景.
- 这种方法可以提高治疗效果并减轻万科米辛的不良影响.
- 进一步的研究和优化对于将这些纳米配方推向临床应用至关重要.
相关概念视频
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:24Microbial Corrosion
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...